9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-7h-furo(3,2-g)(1)benzopyran-7-one and Osteoarthritis

9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-7h-furo(3,2-g)(1)benzopyran-7-one has been researched along with Osteoarthritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
He, L; Jia, Y; Peng, J; Qian, Y; Sun, P; Wang, Y; Yang, Q; Yang, W; Zhang, T; Zhao, K	1

Other Studies

1 other study(ies) available for 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-7h-furo(3,2-g)(1)benzopyran-7-one and Osteoarthritis

Article	Year
Byakangelicin inhibits IL-1β-induced mouse chondrocyte inflammation in vitro and ameliorates murine osteoarthritis in vivo. International immunopharmacology, 2020, Volume: 85 Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Disease Models, Animal; Furocoumarins; Interleukin-1beta; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Osteoarthritis; Tumor Necrosis Factor-alpha	2020

Article

Year

Byakangelicin inhibits IL-1β-induced mouse chondrocyte inflammation in vitro and ameliorates murine osteoarthritis in vivo.

International immunopharmacology, 2020, Volume: 85

Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Disease Models, Animal; Furocoumarins; Interleukin-1beta; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Osteoarthritis; Tumor Necrosis Factor-alpha

2020